• 제목/요약/키워드: 1Alpha-hydroxylase

검색결과 67건 처리시간 0.023초

A case of 17 alpha-hydroxylase deficiency

  • Kim, Sung Mee;Rhee, Jeong Ho
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제42권2호
    • /
    • pp.72-76
    • /
    • 2015
  • $17{\alpha}$-hydroxylase and 17,20-lyase are enzymes encoded by the CYP17A1 gene and are required for the synthesis of sex steroids and cortisol. In $17{\alpha}$-hydroxylase deficiency, there are low blood levels of estrogens, androgens, and cortisol, and resultant compensatory increases in adrenocorticotrophic hormone that stimulate the production of 11-deoxycorticosterone and corticosterone. In turn, the excessive levels of mineralocorticoids lead to volume expansion and hypertension. Females with $17{\alpha}$-hydroxylase deficiency are characterized by primary amenorrhea and delayed puberty, with accompanying hypertension. Affected males usually have female external genitalia, a blind vagina, and intra-abdominal testes. The treatment of this disorder is centered on glucocorticoid and sex steroid replacement. In patients with $17{\alpha}$-hydroxylase deficiency who are being raised as females, estrogen should be supplemented, while genetically female patients with a uterus should also receive progesterone supplementation. Here, we report a case of a 21-year-old female with $17{\alpha}$-hydroxylase deficiency who had received inadequate treatment for a prolonged period of time. We also include a brief review of the recent literature on this disorder.

Microbial $9{\alpha}$-Hydroxylase:Epoxidation of 9(11)-dehydro-$17{\alpha}$-methyl-testosterone

  • Kang, Hee-Kyoung;Lee, Sang-Sup
    • Archives of Pharmacal Research
    • /
    • 제20권6호
    • /
    • pp.525-528
    • /
    • 1997
  • Steroid $9{\alpha}$.-hydroxylase is a key enzyme system in steroid nucleus degradation in company with ${\Delta}$-dehydrogenase. To examine $9{\alpha}$-hydroxylase activity during microbial transformation of steroids, 9(11)-dehydro-$17{\alpha}$-methyl-testosterone was adopted as a stable substrate for preventing the rupture of steroid nucleus. Using Nocardia restrictus ATCC 14887 capable of introducing a $9{\alpha}$-hydroxyl group into steroids, $9{\alpha}$,$11{\alpha}$-oxido-$17{\beta}$-hydroxy-$17{\alpha}$-methyl-4-androstene-3-one and $9{\alpha}$-hydroxyl group into steroids,$9{\alpha}$,$11{\alpha}$-oxido-$17{\beta}$-hydroxy-$17{\alpha}$-methyl-1,4-androstadiene-3- one were obtained. These microbiologically transformed products could be used as reference compounds in the enzyme assay.

  • PDF

Vitamin D dependent rickets type I

  • Kim, Chan-Jong
    • Clinical and Experimental Pediatrics
    • /
    • 제54권2호
    • /
    • pp.51-54
    • /
    • 2011
  • Vitamin D is present in two forms, ergocalciferol (vitamin $D_2$) produced by plants and cholecalciferol (vitamin $D_3$) produced by animal tissues or by the action of ultraviolet light on 7-dehydrocholesterol in human skin. Both forms of vitamin D are biologically inactive pro-hormones that must undergo sequential hydroxylations in the liver and the kidney before they can bind to and activate the vitamin D receptor. The hormonally active form of vitamin D, 1,25-dihydroxyvitamin D3 $[1,25(OH)_2D]$, plays an essential role in calcium and phosphate metabolism, bone growth, and cellular differentiation. Renal synthesis of $1,25(OH)_2D$ from its endogenous precursor, 25-hydroxyvitamin D (25OHD), is the rate-limiting and is catalyzed by the $1{\alpha}$-hydroxylase. Vitamin D dependent rickets type I (VDDR-I), also referred to as vitamin D $1{\alpha}$-hydroxylase deficiency or pseudovitamin D deficiency rickets, is an autosomal recessive disorder characterized clinically by hypotonia, muscle weakness, growth failure, hypocalcemic seizures in early infancy, and radiographic findings of rickets. Characteristic laboratory features are hypocalcemia, increased serum concentrations of parathyroid hormone (PTH), and low or undetectable serum concentrations of $1,25(OH)_2D$ despite normal or increased concentrations of 25OHD. Recent advances have showed in the cloning of the human $1{\alpha}$-hydroxylase and revealed mutations in its gene that cause VDDR-I. This review presents the biology of vitamin D, and $1{\alpha}$-hydroxylase mutations with clinical findings.

고정화 효소를 이용한 7$\alpha$-hydroxycephalosporin C의 합성 (Synthesis of 7$\alpha$-Hydroxycephalosporin C by Immobilized Enzyme)

  • 김정근;강희일;박영훈;최용진;이종욱
    • 미생물학회지
    • /
    • 제37권2호
    • /
    • pp.164-169
    • /
    • 2001
  • Cephamycin C를 생산하는 몇가지 균주를 사용하여 cephalosporin C로부터 7$\alpha$-hydroxycephalosporin C로의 전환력을 조사하였다. 이들 균주중에서 cephalosporin 7$\alpha$-hydroxylase의 활성은 Streptomyces clavuligerus ATCC 27064가 가장 높게 나타났다. Streptomyces clavuligerus ATCC 27064로부터 얻은 조효소액을 정제한 후 activated DEAE-sphacel 레진에 고정화하여 기질인 cephalosporin C로부터 7$\alpha$-hydroxycephalosporin C를 생산하였다. 고정화에 의해서 생성된 물질을 ESI-Mass로 측정한 결과, 분자량 431로 나타났다. 또한 $^1H$ NMR 분석에 의해 고정화 효소에 의해 생성된 물질은 cephalosporin C로부터 얻어진 7$\alpha$-hydroxycephalosporin C임을 확인하였다.

  • PDF

Effects of Hydroxylated Flavonoids on the Ethoxyresorufin O-deethylase and Benzo($\alpha$)pyrene Hydroxylase

  • Sun, Sun-Ho;Sheen, Yhun-Yhong
    • Archives of Pharmacal Research
    • /
    • 제19권6호
    • /
    • pp.514-519
    • /
    • 1996
  • In order to understand the mechanism of action of flavonoids on the drug metabolizing enzyme, cytochrome P450IA1, this study was undertaken to examine the effect of chrysin, morin, myricetin and aminopyrine on the activities of ethoxyresorufin O-deethylase and benzo(.alpha.) pyrene hydroxylase in the liver. In the isolated perfused rat liver that was pretreated with 3-methylcholanthrene (3MC), chrysin, morin, myricetin and aminopyrine inhibited the activity of ethoxyresorufin O-deethylase with concentration dependent manner. The isolated liver perfusion with chrysin, morin, myricetin and aminopyrine showed inhibition on the induction of ethoxyresorufin O- deethylase by 3MC. And also, in mouse liver hepa I cells, 3MC-stimulated the benzo(.alpha.)pyrene hydroxylase activity which was inhibited by chrysin, morin, myricetin and aminopyrine. These results strongly suggested that hydoxylated flavonoids interfered not only the induction of cytochrome P45OIA1 enzymes by 3MC but also the interaction of substrates and enzyme.

  • PDF

Novel Dioxygenases, HIF-α Specific Prolyl-hydroxylase and Asparanginyl-hydroxylase: O2 Switch for Cell Survival

  • Park, Hyun-Sung
    • Toxicological Research
    • /
    • 제24권2호
    • /
    • pp.101-107
    • /
    • 2008
  • Studies on hypoxia-signaling pathways have revealed novel Fe(II) and $\alpha$-ketoglutarate-dependent dioxygenases that hydroxylate prolyl or asparaginyl residues of a transactivator, Hypoxia-Inducible $Factor-\alpha(HIF-\alpha)$ protein. The recognition of these unprecedented dioxygenases has led to open a new paradigm that the hydroxylation mediates an instant post-translational modification of a protein in response to the changes in cellular concentrations of oxygen, reducing agents, or $\alpha$-ketoglutarate. Activity of $HIF-\alpha$ is repressed by two hydroxylases. One is $HIF-\alpha$ specific prolyl-hydroxylases, referred as prolyl-hydroxylase domain(PHD). The other is $HIF-\alpha$ specific asparaginyl-hydroxylase, referred as factor-inhibiting HIF-1(FIH-1). The facts (i) that many dioxygenases commonly use molecular oxygen and reducing agents during detoxification of xenobiotics, (ii) that detoxification reaction produces radicals and reactive oxygen species, and (iii) that activities of both PHD and FIH-1 are regulated by the changes in the balance between oxygen species and reducing agents, imply the possibility that the activity of $HIF-\alpha$ can be increased during detoxification process. The importance of $HIF-\alpha$ in cancer and ischemic diseases has been emphasized since its target genes mediate various hypoxic responses including angiogenesis, erythropoiesis, glycolysis, pH balance, metastasis, invasion and cell survival. Therefore, activators of PHDs and FIH-1 can be potential anticancer drugs which could reduce the activity of HIF, whereas inhibitors, for preventing ischemic diseases. This review highlights these novel dioxygenases, PHDs and FIH-1 as specific target against not only cancers but also ischemic diseases.

Regulatory Effect of 25-hydroxyvitamin $D_3$ on Nitric Oxide Production in Activated Microglia

  • Hur, Jinyoung;Lee, Pyeongjae;Kim, Mi Jung;Cho, Young-Wuk
    • The Korean Journal of Physiology and Pharmacology
    • /
    • 제18권5호
    • /
    • pp.397-402
    • /
    • 2014
  • Microglia are activated by inflammatory and pathophysiological stimuli in neurodegenerative diseases, and activated microglia induce neuronal damage by releasing cytotoxic factors like nitric oxide (NO). Activated microglia synthesize a significant amount of vitamin $D_3$ in the rat brain, and vitamin $D_3$ has an inhibitory effect on activated microglia. To investigate the possible role of vitamin $D_3$ as a negative regulator of activated microglia, we examined the effect of 25-hydroxyvitamin $D_3$ on NO production of lipopolysaccharide (LPS)-stimulated microglia. Treatment with LPS increased the production of NO in primary cultured and BV2 microglial cells. Treatment with 25-hydroxyvitamin $D_3$ inhibited the generation of NO in LPS-activated primary microglia and BV2 cells. In addition to NO production, expression of 1-${\alpha}$-hydroxylase and the vitamin D receptor (VDR) was also upregulated in LPS-stimulated primary and BV2 microglia. When BV2 cells were transfected with 1-${\alpha}$-hydroxylase siRNA or VDR siRNA, the inhibitory effect of 25-hydroxyvitamin $D_3$ on activated BV2 cells was suppressed. 25-Hydroxyvitamin $D_3$ also inhibited the increased phosphorylation of p38 seen in LPS-activated BV2 cells, and this inhibition was blocked by VDR siRNA. The present study shows that 25-hydroxyvitamin $D_3$ inhibits NO production in LPS-activated microglia through the mediation of LPS-induced 1-${\alpha}$-hydroxylase. This study also shows that the inhibitory effect of 25-hydroxyvitamin $D_3$ on NO production might be exerted by inhibiting LPS-induced phosphorylation of p38 through the mediation of VDR signaling. These results suggest that vitamin $D_3$ might have an important role in the negative regulation of microglial activation.

북방산 개구리 난소의 Cytochrome $P450_{C17}$ 유전자 특성 (Characterization of Ovarian Cytochrome $P450_{C17}$ (17 ${\alpha}-hydroxylase$/17,20-lyase) in Rana dybowski)

  • 강해묵
    • 한국발생생물학회지:발생과생식
    • /
    • 제10권2호
    • /
    • pp.127-133
    • /
    • 2006
  • 스테로이드 합성효소 중 $17\;{\alpha}-hydroxylase/17,20-lyase(P450_{C17})$는 progesterone을 $17\;{\alpha}-hydroxyprogesterone$을 거쳐 androstenedione으로 변환을 담당하는 효소이다. 양서류 난소에서 스테로이드 합성의 분자적 조절과정의 연구에 사용할 목적으로 북방산 개구리(Rana dybowskii) 난소에서 $P450_{C17}$ cDNA를 클로닝 하였다. 북방산 개구리 난포세포의 cDNA library 검색을 통해 분리된 약 2.5kb의 cDNA는 529개의 아미노산을 가진 단일 번역틀을 가지고 있었다. 개구리 $P450_{C17}$의 아미노산 서열은 Xenopus와는 76%, 닭과는 63%, 그리고 사람과는 약 45%의 동일성을 보여 주였고, 동시에 진화적으로 척추동물에서 매우 잘 보존된 아미노산 서열을 가지고 있었다. 노던 분석에서 개구리의 $P450_{C17}$ 전사체는 난소에서만 2.5kb와 3.6kb 크기의 두 종류가 발견되었다. 그리고 개구리 Rana $P450_{C17}$ cDNA는 비스테로이드 합성 세포인 COS-1세포에서 분명한 $17\;{\alpha}-hydroxylase/17,20-lyase$ 활성을 주었다. 따라서 클로닝된 개구리 $P450_{C17}$ 유전자는 양서류의 난소에서 스테로이드 합성의 분자적 기작을 연구하는데 매우 유용할 것으로 사료된다.

  • PDF

17α-Hydroxylase 결핍에 인한 남성가성반음양 1례 (A Case of Male Pseudohermaphroditism due to 17α-Hydroxylase Deficiency)

  • 박경아;정연경;이정렬;최영민;이경훈;김희승;지병철;구승엽;서창석;김석현;김정구;문신용;김성연
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제33권2호
    • /
    • pp.133-138
    • /
    • 2006
  • 46,XY 핵형인 남성에게서 $17{\alpha}$-hydroxylase의 결핍이 있을 경우 성호르몬의 생성장애로 인해 남성가성반음양에 의한 여성 표현형을 보이게 된다. 코티졸이 결핍되면 부신피질자극호르몬의 증가 및 이로 인한 광불무신피질호르몬의 합성이 증가되어 저레닌성 고혈압, 저칼륨혈증이 발생한다. 41세 된 여자 환자가 원발성 무월경과 고혈압을 주소로 내원하였다. 46,XY 핵형을 보였으며, 호르몬 검사상, 혈중 에스트라디올, 테스토스테론, 레닌, 코티졸이 감소되어 있으며 부신피질자극호르몬 및 deoxycorticosterone이 증가되어 있어 $17{\alpha}$-hydroxylase 결핍에 의한 남성가성반음양으로 진단되었다. 이 질환의 치료로 복강경을 이용한 양측 고환적출술을 시행하였고, 부신피질호르몬과 항고혈압 재제, 에스트로젠을 투여하였다. 본 연구에서는 위 증례에 대하여 간단한 문헌고찰과 함께 보고하는 바이다.

Complete Recovery of Oxysterol 7α-Hydroxylase Deficiency by Living Donor Transplantation in a 4-Month-Old Infant: the First Korean Case Report and Literature Review

  • Hong, Jeana;Oh, Seak Hee;Yoo, Han-Wook;Nittono, Hiroshi;Kimura, Akihiko;Kim, Kyung Mo
    • Journal of Korean Medical Science
    • /
    • 제33권51호
    • /
    • pp.324.1-324.6
    • /
    • 2018
  • Oxysterol $7{\alpha}$-hydroxylase deficiency is a very rare liver disease categorized as inborn errors of bile acid synthesis, caused by CYP7B1 mutations. As it may cause rapid progression to end-stage liver disease even in early infancy, a high index of suspicion is required to prevent fatal outcomes. We describe the case of a 3-month-old boy with progressive cholestatic hepatitis and severe hepatic fibrosis. After excluding other etiologies for his early liver failure, we found that he had profuse urinary excretion of $3{\beta}$-monohydroxy-${\Delta}^5$-bile acid derivatives by gas chromatography/mass spectrometry analysis with dried urine spots on filter paper. He was confirmed to have a compound heterozygous mutation (p.Arg388Ter and p.Tyr469IlefsX5) of the CYP7B1 gene. After undergoing liver transplantation (LT) from his mother at 4 months of age, his deteriorated liver function completely normalized, and he had normal growth and development until the current follow-up at 33 months of age. We report the first Korean case of oxysterol $7{\alpha}$-hydroxylase deficiency in the youngest infant reported to undergo successful living donor LT to date.